-
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
21 Jan 2025 07:30 GMT
… 3 unresectable non-small cell lung cancer receiving standard of care chemoradiation … study in non-small cell lung cancer brings us another step closer … radiation therapy, with or without cetuximab, for the treatment of patients …
-
The Targeted Pulse: Check Out Positive and Negative Updates in Head and Neck Cancer, and How the FDA is Handling Advancements in Lung Cancer Treatment
19 Jan 2025 19:53 GMT
… ), when compared with cetuximab (Erbitux), did not improve progression … the Fact Track for Lung Cancer Surgery
Injection abenacianine … existing deficits in lung cancer surgery by helping … [patients with] EGFR-positive lung cancer. These MARIPOSA results show …
-
Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report
17 Jan 2025 14:00 GMT
… , including non-small cell lung cancer (NSCLC), colorectal carcinoma ( … monoclonal antibodies (mAbs) (eg cetuximab, panitumumab, pertuzumab) and … during treatment of lung cancer and colorectal carcinoma … association and Taiwan Lung Cancer Society on the …
-
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 Jan 2025 18:00 GMT
… (encorafenib) with cetuximab (ERBITUX) for treating adults … Cell Lung Cancer Market Non-small Cell Lung Cancer Market … Small-Cell Lung Cancer Market Small-Cell Lung Cancer Market Insight … Small-Cell Lung Cancer Pipeline Small-Cell Lung Cancer Pipeline Insight …
-
Breaking Down the CONVERGE Study of NBTXR3 in Stage 3 Unresectable NSCLC
29 Jan 2025 03:16 GMT
… III unresectable non–small cell lung cancer (NSCLC), the first participant has … study in [non-small cell lung cancer] NSCLC brings us another step … by radiotherapy, with or without cetuximab, for patients with locally advanced …
-
The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer
14 Nov 2024 16:06 GMT
… therapeutic strategies available for lung cancer. Notably, combination therapies … alpha inhibitors, bevacizumab, and cetuximab, in an effort to … -L1 expression in human lung cancers. PLoS One. 2016; … p110α with RAS in lung tumor maintenance. Cancer Cell. 2013 …
-
Cetuximab Outperforms Durvalumab for Head and Neck Cancer When Cisplatin Isn’t an Option
19 Dec 2024 13:11 GMT
… given the targeted drug cetuximab (Erbitux) along with radiation therapy … pembrolizumab (Keytruda) and cetuximab in people with locally … patient survival compared with cetuximab and radiation therapy.
“ … helped some patients with lung cancer live longer in a …
-
Updated CheckMate -8HW Trial Results Show Significant Survival Benefit with Opdivo Plus Yervoy in MSI-H/dMMR Colorectal Cancer
27 Jan 2025 15:56 GMT
… mesothelioma; and non-small cell lung cancer (NSCLC).3
Opdivo is a … with or without bevacizumab or cetuximab.
The dual primary endpoints of …
-
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
27 Jan 2025 14:00 GMT
… DaRT in treating liver metastases, lung cancer and rectal cancer - JERUSALEM … DaRT treatment delivered into a lung tumor, ten Alpha DaRT sources were … alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or …
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
14 Sep 2024 08:50 GMT
… metastatic non-small cell lung cancer (NSCLC). After an … approximately 80-85% of lung cancers,2 with BRAF V600E … BRAFTOVI in combination with cetuximab and FOLFIRI chemotherapy in … American Lung Association. BRAF and lung cancer. Available at: https:…
About
© 1995-2025